HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹908 Cr | ₹851 Cr | ₹799 Cr | ₹655 Cr | ₹545 Cr |
What is the latest Appropriations of HIKAL ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹908 Cr |
| Mar2024 | ₹851 Cr |
| Mar2023 | ₹799 Cr |
| Mar2022 | ₹655 Cr |
| Mar2021 | ₹545 Cr |
How is Appropriations of HIKAL Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹908 Cr | 6.66 | |
| Mar2024 | ₹851 Cr | 6.56 | |
| Mar2023 | ₹799 Cr | 22.04 | |
| Mar2022 | ₹655 Cr | 20.03 | |
| Mar2021 | ₹545 Cr | - | |
Compare Appropriations of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,527.7 Cr | 4.4% | 8.2% | -49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 4.4% |
8.2% |
-49.4% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses